unknown
Stage
3
Investors
About
Alia Therapeutics is a gene editing company focused on developing genetic medicines aimed at curing genetic diseases by targeting genomic sites that are currently inaccessible.
Explore Alia Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.